Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,330,000 | 3,497,000 | 10,514,000 | 7,947,000 | 5,318,000 |
| Depreciation Amortization | 2,026,000 | 1,036,000 | 3,666,000 | 2,630,000 | 1,625,000 |
| Income taxes - deferred | 92,000 | 365,000 | -39,000 | -324,000 | -511,000 |
| Accounts receivable | -676,000 | -445,000 | 83,000 | 180,000 | 238,000 |
| Other Working Capital | -2,264,000 | -2,992,000 | -969,000 | -1,134,000 | -1,129,000 |
| Other Operating Activity | 820,000 | 816,000 | 2,141,000 | 2,721,000 | 1,499,000 |
| Operating Cash Flow | $7,328,000 | $2,277,000 | $15,396,000 | $12,020,000 | $7,040,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,210,000 | -480,000 | -1,425,000 | -877,000 | -410,000 |
| Net Acquisitions | -174,000 | -168,000 | -4,486,000 | -4,423,000 | -4,324,000 |
| Purchase Of Investment | -8,569,000 | -3,551,000 | -13,434,000 | -8,837,000 | -5,211,000 |
| Sale Of Investment | 7,997,000 | 2,800,000 | 14,797,000 | 12,134,000 | 9,883,000 |
| Other Investing Activity | -16,000 | -4,000 | 38,000 | -4,000 | -8,000 |
| Investing Cash Flow | $-1,972,000 | $-1,403,000 | $-4,510,000 | $-2,007,000 | $-70,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,682,000 | 475,000 | 3,268,000 | 3,606,000 | 2,518,000 |
| Debt Issued | 6,000 | 6,000 | 45,000 | 16,000 | 6,000 |
| Debt Repayment | -1,504,000 | -1,000 | -804,000 | -796,000 | -10,000 |
| Common Stock Issued | 1,842,000 | 1,123,000 | 2,720,000 | 1,817,000 | 1,148,000 |
| Common Stock Repurchased | 0 | N/A | -12,919,000 | -12,919,000 | -12,919,000 |
| Dividend Paid | -3,562,000 | -1,706,000 | -6,614,000 | -4,924,000 | -3,241,000 |
| Other Financing Activity | -1,218,000 | -674,000 | -6,258,000 | -5,891,000 | -4,940,000 |
| Financing Cash Flow | $-2,754,000 | $-777,000 | $-20,562,000 | $-19,091,000 | $-17,438,000 |
| Exchange Rate Effect | -206,000 | -153,000 | 45,000 | 22,000 | -32,000 |
| Beginning Cash Position | 14,911,000 | 14,911,000 | 24,542,000 | 24,542,000 | 24,542,000 |
| End Cash Position | 17,307,000 | 14,855,000 | 14,911,000 | 15,486,000 | 14,042,000 |
| Net Cash Flow | $2,396,000 | $-56,000 | $-9,631,000 | $-9,056,000 | $-10,500,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,328,000 | 2,277,000 | 15,396,000 | 12,020,000 | 7,040,000 |
| Capital Expenditure | -1,357,000 | -586,000 | -2,934,000 | -1,782,000 | -1,100,000 |
| Free Cash Flow | 5,971,000 | 1,691,000 | 12,462,000 | 10,238,000 | 5,940,000 |